Patents by Inventor Jeffrey W. Guentensberger

Jeffrey W. Guentensberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Terazosin capsules
    Patent number: 6110493
    Abstract: A capsule dosage form containing solid form of terazosin in a solid carrier is disclosed. The capsule dosage form is stable under accelerated stability conditions and therapeutically equivalent to known liquid-filled terazosin capsules.
    Type: Grant
    Filed: May 18, 1999
    Date of Patent: August 29, 2000
    Assignee: Novartis Corporation
    Inventors: Jeffrey W. Guentensberger, Christopher L. Pelloni
  • Terazosin capsules
    Patent number: 5952003
    Abstract: A capsule dosage form containing solid form of terazosin in a solid carrier is disclosed. The capsule dosage form is stable under accelerated stability conditions and therapeutically equivalent to known liquid-filled terazosin capsules.
    Type: Grant
    Filed: August 1, 1996
    Date of Patent: September 14, 1999
    Assignee: Novartis Corporation
    Inventors: Jeffrey W. Guentensberger, Christopher L. Pelloni